Search research articles
Contact Us
Filters
Showing results (341-350 of 518) with videos related to
Page
of 52
Sort By:
American Journal of Medical Genetics. Part A
|
November 10, 2021
Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling
Bettina Meiser, Phyllis Butow, Grace Davies, et al.
Leukemia & Lymphoma
|
February 15, 2011
Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group
Andrew Wirth, Andrew Grigg, Max Wolf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome
Nigel Spry, Jennifer Harvey, Craig Macleod, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib
Chee Khoon Lee, David Goldstein, Emma Gibbs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments
J Matt McCrary, David Goldstein, Terry Trinh, et al.
Head & Neck
|
July 28, 2025
PET-CT Test Properties for HPV Positive Unknown Primary of the Neck: A FIND Trial Correlative Study
Sharon Tzelnick, Ur Metser, Eugene Yu, et al.
ANZ Journal of Surgery
|
March 29, 2007
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601
Michael Findlay, David Storey, Val Gebski, et al.
Pancreas
|
June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
David Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.
The Oncologist
|
January 14, 2015
Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
Josep Tabernero, E Gabriela Chiorean, Jeffrey R Infante, et al.
Targeted Oncology
|
March 15, 2022
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours
Tiffany Foo, David Goldstein, Eva Segelov, et al.
Page
of 52
Search research articles
Search
Showing results (341-350 of 518) with videos related to
Sort By:
Page
of 52
American Journal of Medical Genetics. Part A
|
November 10, 2021
Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling
Bettina Meiser, Phyllis Butow, Grace Davies, et al.
Leukemia & Lymphoma
|
February 15, 2011
Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group
Andrew Wirth, Andrew Grigg, Max Wolf, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 2008
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome
Nigel Spry, Jennifer Harvey, Craig Macleod, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib
Chee Khoon Lee, David Goldstein, Emma Gibbs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments
J Matt McCrary, David Goldstein, Terry Trinh, et al.
Head & Neck
|
July 28, 2025
PET-CT Test Properties for HPV Positive Unknown Primary of the Neck: A FIND Trial Correlative Study
Sharon Tzelnick, Ur Metser, Eugene Yu, et al.
ANZ Journal of Surgery
|
March 29, 2007
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601
Michael Findlay, David Storey, Val Gebski, et al.
Pancreas
|
June 17, 2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
David Goldstein, Daniel D Von Hoff, E Gabriela Chiorean, et al.
The Oncologist
|
January 14, 2015
Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
Josep Tabernero, E Gabriela Chiorean, Jeffrey R Infante, et al.
Targeted Oncology
|
March 15, 2022
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours
Tiffany Foo, David Goldstein, Eva Segelov, et al.
Page
of 52